Magnera (MAGN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
5 Feb, 2026Executive summary
Net sales for the quarter were $792 million, with strong performance in wipes, infrastructure, and successful merger integration, supporting sequential earnings improvement and 2026 Adjusted EBITDA guidance of 9% growth.
Adjusted EBITDA for the quarter was $93 million, up 11% year-over-year, driven by synergy realization, Project Core transformation, and merger benefits.
Operations are organized into Americas and Rest of World segments, focusing on personal care and consumer solutions across multiple regions.
Strategic focus on cost structure, innovation, and commercial excellence positions the company for sustained long-term success.
Fiscal 2026 guidance for adjusted EBITDA of $380–$410 million and free cash flow of $90–$110 million was reaffirmed.
Financial highlights
Q1 net sales were $792 million, up 13% year-over-year, with $112 million from the merger and $36 million from favorable currency, partially offset by lower selling prices and a 1% organic volume decline.
Adjusted EBITDA was $93 million, with margin improving to 11.7% and $8 million contribution from the merger.
Operating income improved to $14 million from a loss of $22 million in the prior year quarter.
Free cash flow for the quarter was $2 million, with $15 million in capital expenditures.
Cash and cash equivalents at quarter-end were $264 million.
Outlook and guidance
Fiscal 2026 guidance reaffirmed: adjusted EBITDA of $380–$410 million, free cash flow of $90–$110 million, and cash flow from operations of $170–$190 million.
2026 Adjusted EBITDA guidance targets 9% growth, primarily driven by synergy realization and Project Core initiatives.
Free cash flow for 2026 expected at ~$100 million, assuming flat working capital, $135 million interest, $80 million integration costs, and $80 million CapEx.
Capex outlook remains at 2–3% of sales, with a focus on deleveraging to a leverage target of ~3.0x.
Volume growth for 2026 expected to be flat overall, with North America slightly positive, Europe down ~3%, and South America stabilizing.
Latest events from Magnera
- All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 20269 Mar 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong ESG focus.MAGN
Proxy filing14 Jan 2026 - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing14 Jan 2026 - Q1 sales rose 35% to $702M post-merger, with EBITDA up 8% and widened losses from integration costs.MAGN
Q1 202523 Dec 2025 - Strong Q4, raised 2026 outlook, and innovation drive global growth and operational excellence.MAGN
BofA Securities Leveraged Finance Conference 20253 Dec 2025 - Net sales hit $839M, EBITDA $91M; merger and cost initiatives offset market softness.MAGN
Q3 202523 Nov 2025 - Q2 sales up 48% to $824M on merger, but net loss and lower EBITDA guidance issued.MAGN
Q2 202521 Nov 2025 - 2026 EBITDA to rise 9% on synergies, with robust cash flow and improved leverage.MAGN
Q4 202520 Nov 2025 - Synergy realization and operational optimization drive growth and margin recovery into 2027.MAGN
Wells Fargo Industrials & Materials Conference 202510 Nov 2025